Pursuant to the above inspection by United States Food and Drug Administration (USFDA), the Company has now received the Establishment Inspection Report (EIR) indicating closure of inspection and classifying the facility as "no action indicated" (NAI).

Based on this inspection and the USFDA NAI classification, this facility is in compliance with regard to current good manufacturing practices (cGMP).